Eli Lilly (LLY) is showing strong bullish momentum, currently trading within an ascending channel on the 1-hour timeframe. The stock recently tested the upper trendline and is consolidating near $900, a key psychological level.
Key observations: * Trend Structure: LLY is in a strong uptrend, forming higher highs and higher lows within a well-defined price channel.
* Support & Resistance: * Major Resistance: $912 (recent high) * Key Support: $894, followed by $881 * Stronger Support Zones: $869 - $865 (confluence with PUT walls)
* MACD Indicator: Bullish momentum persists but shows slight signs of cooling off. Watch for potential continuation.
* Stoch RSI: Approaching overbought conditions, which may signal a slight pullback before another push higher.
Options Flow & GEX Analysis The GEX (Gamma Exposure) indicator suggests a high call concentration around $900, aligning with our price action resistance. This means market makers may hedge aggressively if LLY sustains above this level, fueling further upside.
* IVR (Implied Volatility Rank): 19, with IVx avg at 32.7%, indicating relatively lower volatility. * Call Side Bias: 23.4% of total options flow supports a bullish breakout scenario. * Key GEX Levels: * Strongest Resistance / CALL Wall: $900 → Break and hold here unlocks $920 (2nd CALL Wall). * PUT Support Zone: $865 - $867.5 → A breakdown could trigger downside hedging, making this a critical level to hold.
Final Thoughts LLY is one of the strongest setups on my radar. If it maintains above $900, it could trigger a gamma squeeze toward $920. However, failure to hold this level could result in a retest of $865-$869. Options positioning suggests a bullish bias, but watching price action closely is key.
📢 Risk Management: Always size positions according to your risk tolerance. Trade the setup, not the expectation.
🔹 Disclaimer: This analysis is for educational purposes only and does not constitute financial advice. Always conduct your own research and manage risk accordingly before trading.
As informações e publicações não devem ser e não constituem conselhos ou recomendações financeiras, de investimento, de negociação ou de qualquer outro tipo, fornecidas ou endossadas pela TradingView. Leia mais em Termos de uso.
As informações e publicações não devem ser e não constituem conselhos ou recomendações financeiras, de investimento, de negociação ou de qualquer outro tipo, fornecidas ou endossadas pela TradingView. Leia mais em Termos de uso.